Mri and ultrasonography in staging prostate cancer

Thomas C. Gasser, Karl Streule, Andreas Nidecker, Markus Rist, Matthew D. Rifkin, Constantine A. Gatsonis, Barbara J. Mcneil, Leslie E. Quint, David M. Paushter, Elias A. Zerhouni, Jonathan I. Epstein, Ulrike Hamper, Patrick C. Walsh

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: The article by Dr. Rifkin et al. (Sept. 6 issue)1 on the evaluation of the role of magnetic resonance imaging (MRI) and transrectal sonography in staging localized carcinoma of the prostate reports poor results that are consistent with our clinical experience. Unfortunately, the authors did not compare these relatively new imaging techniques with computed tomography (CT), which in many institutions is still the standard technique used for the staging of carcinoma of the prostate. In a recent pilot study we compared the accuracy of CT and MRI in staging localized carcinoma of the prostate. Ten patients with.

Original languageEnglish (US)
Pages (from-to)494-495
Number of pages2
JournalNew England Journal of Medicine
Volume324
Issue number7
DOIs
StatePublished - Feb 14 1991

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Mri and ultrasonography in staging prostate cancer'. Together they form a unique fingerprint.

Cite this